Envoy Medical (COCH) Stock Forecast, Price Target & Predictions
COCH Stock Forecast
Envoy Medical stock forecast is as follows: an average price target of $6.00 (represents a 275.00% upside from COCH’s last price of $1.60) and a rating consensus of 'Buy', based on 3 wall street analysts offering a 1-year stock forecast.
COCH Price Target
The average price target for Envoy Medical (COCH) is $6.00 based on 1-year price targets from 3 Wall Street analysts in the past 3 months, with a price target range of $6.00 to $6.00. This represents a potential 275.00% upside from COCH's last price of $1.60.
COCH Analyst Ratings
According to 3 Wall Street analysts, Envoy Medical's rating consensus is 'Buy'. The analyst rating breakdown for COCH stock is 0 'Strong Buy' (0.00%), 3 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Envoy Medical Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Apr 03, 2024 | Frank Takkinen | Loop Capital Markets | $6.00 | $4.48 | 33.93% | 275.00% |
| Apr 03, 2024 | Frank Takkinen | Lake Street | $6.00 | $4.48 | 33.93% | 275.00% |
The latest Envoy Medical stock forecast, released on Apr 03, 2024 by Frank Takkinen from Loop Capital Markets, set a price target of $6.00, which represents a 33.93% increase from the stock price at the time of the forecast ($4.48), and a 275.00% increase from COCH last price ($1.60).
Envoy Medical Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 2 |
| Avg Price Target | - | - | $6.00 |
| Last Closing Price | $1.60 | $1.60 | $1.60 |
| Upside/Downside | -100.00% | -100.00% | 275.00% |
In the current month, the average price target of Envoy Medical stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Envoy Medical's last price of $1.60. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Nov 19, 2024 | Brookline Capital | Buy | Buy | Hold |
| Jun 24, 2024 | Ascendiant | Buy | Initialise | |
| Apr 03, 2024 | Lake Street | Buy | Buy | Hold |
Envoy Medical's last stock rating was published by Brookline Capital on Nov 19, 2024. The company gave COCH a "Buy" rating, the same as its previous rate.
Envoy Medical Financial Forecast
Envoy Medical Revenue Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - |
| Avg Forecast | $86.67K | $86.67K | $90.00K | $86.67K | $83.75K | $75.00K | $82.50K | $87.50K | $75.00K |
| High Forecast | $107.45K | $107.45K | $111.59K | $99.05K | $95.71K | $92.99K | $102.29K | $108.49K | $92.99K |
| Low Forecast | $69.08K | $69.08K | $71.73K | $74.29K | $71.78K | $59.78K | $65.76K | $69.74K | $59.78K |
| # Analysts | 1 | 1 | 1 | 2 | 3 | 1 | 1 | 1 | 1 |
| Surprise % | - | - | - | - | - | - | - | - | - |
Envoy Medical's average Quarter revenue forecast for undefined based on undefined analysts is $NaN, with a low forecast of $NaN, and a high forecast of $NaN. COCH's average Quarter revenue forecast represents a NaN% decrease compared to the company's last Quarter revenue of $NaN (undefined).
Envoy Medical EBITDA Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 2 | 3 | 1 | 1 | 1 | 1 |
| EBITDA | - | - | - | - | - | - | - | - | - |
| Avg Forecast | $-43.33K | $-43.33K | $-45.00K | $-43.33K | $-41.88K | $-37.50K | $-41.25K | $-43.75K | $-37.50K |
| High Forecast | $-34.54K | $-34.54K | $-35.87K | $-37.14K | $-35.89K | $-29.89K | $-32.88K | $-34.87K | $-29.89K |
| Low Forecast | $-53.73K | $-53.73K | $-55.79K | $-49.52K | $-47.86K | $-46.49K | $-51.14K | $-54.24K | $-46.49K |
| Surprise % | - | - | - | - | - | - | - | - | - |
undefined analysts predict COCH's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Envoy Medical's previous annual EBITDA (undefined) of $NaN.
Envoy Medical Net Income Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 2 | 3 | 1 | 1 | 1 | 1 |
| Net Income | - | - | - | - | - | - | - | - | - |
| Avg Forecast | $-6.08M | $-6.08M | $-6.54M | $-6.73M | $-6.52M | $-5.35M | $-4.95M | $-4.41M | $-3.73M |
| High Forecast | $-4.48M | $-4.48M | $-4.81M | $-5.39M | $-4.94M | $-3.94M | $-3.65M | $-3.25M | $-2.74M |
| Low Forecast | $-7.98M | $-7.98M | $-8.58M | $-8.08M | $-7.71M | $-7.01M | $-6.50M | $-5.79M | $-4.89M |
| Surprise % | - | - | - | - | - | - | - | - | - |
Envoy Medical's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. COCH's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
Envoy Medical SG&A Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 2 | 3 | 1 | 1 | 1 | 1 |
| SG&A | - | - | - | - | - | - | - | - | - |
| Avg Forecast | $1.12M | $1.12M | $1.17M | $1.12M | $1.09M | $973.43K | $1.07M | $1.14M | $973.43K |
| High Forecast | $1.39M | $1.39M | $1.45M | $1.29M | $1.24M | $1.21M | $1.33M | $1.41M | $1.21M |
| Low Forecast | $896.57K | $896.57K | $931.05K | $964.16K | $931.70K | $775.88K | $853.46K | $905.18K | $775.88K |
| Surprise % | - | - | - | - | - | - | - | - | - |
Envoy Medical's average Quarter SG&A projection for undefined is $NaN, based on undefined Wall Street analysts, with a range of $NaN to $NaN. The forecast indicates a NaN% fall compared to COCH last annual SG&A of $NaN (undefined).
Envoy Medical EPS Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 2 | 3 | 1 | 1 | 1 | 1 |
| EPS | - | - | - | - | - | - | - | - | - |
| Avg Forecast | $-0.31 | $-0.31 | $-0.33 | $-0.34 | $-0.33 | $-0.27 | $-0.25 | $-0.23 | $-0.19 |
| High Forecast | $-0.23 | $-0.23 | $-0.25 | $-0.27 | $-0.25 | $-0.20 | $-0.19 | $-0.17 | $-0.14 |
| Low Forecast | $-0.41 | $-0.41 | $-0.44 | $-0.41 | $-0.39 | $-0.36 | $-0.33 | $-0.30 | $-0.25 |
| Surprise % | - | - | - | - | - | - | - | - | - |
According to undefined Wall Street analysts, Envoy Medical's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to COCH previous annual EPS of $NaN (undefined).